• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Concentration of dipropylacetate in plasma.

作者信息

Loiseau P, Brachet A, Henry P

出版信息

Epilepsia. 1975 Nov;16(4):609-15. doi: 10.1111/j.1528-1157.1975.tb04743.x.

DOI:10.1111/j.1528-1157.1975.tb04743.x
PMID:1107022
Abstract

Dipropylacetate is absorbed rapidly and attains a maximum concentration in serum 1 to 3 hr after ingestion. Since its half-life is on the order of 8 to 10 hr, it must be prescribed three times a day, every 8 hr. It reaches a stable concentration in blood within 48 hr after treatment is begun (by contrast with diphenylhydantoin and phenobarbital) and might therefore be useful when seizures must be controlled quickly. The serum concentration can be altered by some other anticonvulsant drugs, but these interactions should be studied in more detail. The serum concentration varies considerably in the course of a day and from one day to the next in the same subject, which makes it difficult to adjust the blood level. Depamide is rapidly transformed in vivo to dipropylacetate.

摘要

相似文献

1
Concentration of dipropylacetate in plasma.
Epilepsia. 1975 Nov;16(4):609-15. doi: 10.1111/j.1528-1157.1975.tb04743.x.
2
Pharmacokinetics of di-n-propylacetate in epileptic patients.癫痫患者中丙二酸二正丙酯的药代动力学
Eur J Clin Pharmacol. 1975 Feb 28;8(2):97-105. doi: 10.1007/BF00561557.
3
[Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].丙戊酸治疗癫痫,特别强调血清水平测定(作者译)
Fortschr Neurol Psychiatr Grenzgeb. 1978 Jun;46(6):327-41.
4
Elevation of diphenylhydantoin and primidone serum concentration by addition of dipropylacetate, a new anticonvulsant drug.
Acta Paediatr Scand. 1975 Sep;64(5):771-2. doi: 10.1111/j.1651-2227.1975.tb03919.x.
5
[Problems in serum-level determination during valproic acid therapy].[丙戊酸治疗期间血清水平测定的问题]
Arzneimittelforschung. 1977;27(6):1215-21.
6
Drug interactions during anticonvulsant therapy in childhood: diphenylhydantoin, primidone, phenobarbitone, clonazepam, nitrazepam, carbamazepin and dipropylacetate.儿童抗惊厥治疗期间的药物相互作用:苯妥英、扑米酮、苯巴比妥、氯硝西泮、硝西泮、卡马西平和丙戊酸。
Neuropadiatrie. 1977 Feb;8(1):29-41. doi: 10.1055/s-0028-1091502.
7
[Clinical study of serum level of dipropylacetic acid sodium (Depakene) by gaschromatography (author's transl)].
No To Shinkei. 1977 Aug;29(8):885-90.
8
Gas chromatographic measurement of plasma levels of sodium valproate: tentative therapeutic range of a new anticonvulsant in the treatment of refractory epileptics.气相色谱法测定丙戊酸钠的血浆水平:一种新型抗惊厥药物治疗难治性癫痫患者的初步治疗范围
Clin Exp Pharmacol Physiol. 1978 Jan-Feb;5(1):67-73. doi: 10.1111/j.1440-1681.1978.tb00653.x.
9
Interlaboratory variability of valproic acid determinations.丙戊酸测定的实验室间变异性。
Arzneimittelforschung. 1977;27(5):1078-81.
10
Plasma levels of di-no-propylacetate and clonazepam in epileptic patients.
Int J Clin Pharmacol Biopharm. 1977 Sep;15(9):403-8.

引用本文的文献

1
Clinical Consequences of Disproportionate Free Valproate Elevation in Critically Ill Adult Patients: A Multicenter Retrospective Cohort Study.重症成年患者游离丙戊酸异常升高的临床后果:一项多中心回顾性队列研究
Neurocrit Care. 2025 Mar 25. doi: 10.1007/s12028-025-02243-y.
2
Epilepsy care cascade, treatment gap and its determinants in rural South Africa.南非农村地区的癫痫治疗流程、治疗缺口及其决定因素。
Seizure. 2020 Aug;80:175-180. doi: 10.1016/j.seizure.2020.06.013. Epub 2020 Jun 9.
3
Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex.
基于生理学的丙戊酸和丙戊酸钠处置及药物相互作用的药代动力学模型。
Eur J Pharm Sci. 2018 Jan 1;111:465-481. doi: 10.1016/j.ejps.2017.10.009. Epub 2017 Oct 10.
4
Drug level monitoring in paediatric practice.儿科临床中的药物浓度监测
Arch Dis Child. 1980 Feb;55(2):89-98. doi: 10.1136/adc.55.2.89.
5
Diurnal variations in steady-state plasma concentrations of valproic acid in epileptic patients.癫痫患者丙戊酸稳态血浆浓度的昼夜变化。
Clin Pharmacokinet. 1982 Nov-Dec;7(6):544-52. doi: 10.2165/00003088-198207060-00004.
6
Some clinical pharmacological aspects of n-dipropylacetamide.
Ital J Neurol Sci. 1980 Oct;1(4):245-9. doi: 10.1007/BF02336705.
7
Absorption rate and bioavailability of valproic acid and its sodium from rectal dosage forms.
Eur J Clin Pharmacol. 1980 Apr;17(4):309-15. doi: 10.1007/BF00625806.
8
Clinical pharmacokinetics of valproic acid.丙戊酸的临床药代动力学
Clin Pharmacokinet. 1980 Jan-Feb;5(1):67-83. doi: 10.2165/00003088-198005010-00002.
9
Intra-daily oscillations in dipropylacetic acid plasma levels with two or three daily doses of dipropylacetamide in epileptic patients.
Ital J Neurol Sci. 1983 Jun;4(2):173-7. doi: 10.1007/BF02043901.
10
Transplacental passage and half-life of sodium valproate in infants born to epileptic mothers.癫痫母亲所生婴儿中丙戊酸钠的经胎盘转运及半衰期
Br J Clin Pharmacol. 1983 Apr;15(4):503-6. doi: 10.1111/j.1365-2125.1983.tb01541.x.